Suppr超能文献

接受氟哌啶醇治疗患者QTc间期延长的风险管理:比利时一家大学医院的流行病学研究

Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.

作者信息

Vandael Eline, Vandenberk Bert, Vandenberghe Joris, Spriet Isabel, Willems Rik, Foulon Veerle

机构信息

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven - University of Leuven, Herestraat 49, Box 521, 3000, Leuven, Belgium.

Department of Cardiovascular Sciences, KU Leuven - University of Leuven, 3000, Leuven, Belgium.

出版信息

Int J Clin Pharm. 2016 Apr;38(2):310-20. doi: 10.1007/s11096-015-0242-9. Epub 2016 Jan 9.

Abstract

BACKGROUND

Many drugs, including haloperidol, are linked with a risk of QTc-prolongation, which can lead to Torsade de Pointes and sudden cardiac death.

OBJECTIVE

To investigate the prevalence of concomitant risk factors for QTc-prolongation in patients treated with haloperidol, and the use of safety measures to minimize this risk.

SETTING

University Hospitals of Leuven, Belgium. Methods A retrospective epidemiological study was performed. On 15 consecutive Mondays, all patients with a prescription for haloperidol were included. A risk score for QTc-prolongation, inspired by the pro-QTc score of Haugaa et al., was calculated based on gender, comorbidities, lab results and concomitant QTc-prolonging drugs (each factor counting for one point). Available electrocardiograms before and during the treatment of haloperidol were registered.

MAIN OUTCOME MEASURE

Management of the risk of QTc-prolongation.

RESULTS

Two hundred twenty-two patients were included (59.0 % men, median age 77 years) of whom 26.6 % had a risk score of ≥4 (known to significantly increase the mortality). Overall, 24.3 % received haloperidol in combination with other drugs with a known risk of Torsade de Pointes. Half of the patients had an electrocardiogram in the week before the start of haloperidol; only in one-third a follow-up electrocardiogram during haloperidol treatment was performed. Of the patients with a moderately (n = 41) or severely (n = 14) prolonged QTc-interval before haloperidol, 48.8 % and 42.9 % respectively had a follow-up electrocardiogram. In patients with a risk score ≥4, significantly more electrocardiograms were taken before starting haloperidol (p = 0.020).

CONCLUSIONS

Although many patients had risk factors for QTc-prolongation (including the use of other QTc-prolonging drugs) or had a prolonged QTc on a baseline electrocardiogram, follow-up safety measures were limited. Persistent efforts should be taken to develop decision support systems to manage this risk.

摘要

背景

包括氟哌啶醇在内的许多药物都与QTc间期延长风险有关,这可能导致尖端扭转型室速和心源性猝死。

目的

调查接受氟哌啶醇治疗的患者中QTc间期延长相关危险因素的患病率,以及为将该风险降至最低而采取的安全措施的使用情况。

地点

比利时鲁汶大学医院。方法 进行了一项回顾性流行病学研究。在连续15个周一,纳入所有开具氟哌啶醇处方的患者。基于性别、合并症、实验室检查结果和同时使用的QTc间期延长药物(每个因素计1分),计算受Haugaa等人的QTc评分启发的QTc间期延长风险评分。记录氟哌啶醇治疗前和治疗期间的可用心电图。

主要观察指标

QTc间期延长风险的管理。

结果

纳入222例患者(男性占59.0%,中位年龄77岁),其中26.6%的患者风险评分为≥4(已知会显著增加死亡率)。总体而言,24.3%的患者接受氟哌啶醇与其他已知有尖端扭转型室速风险的药物联合使用。一半的患者在开始使用氟哌啶醇前一周进行了心电图检查;在氟哌啶醇治疗期间,只有三分之一的患者进行了随访心电图检查。在氟哌啶醇治疗前QTc间期中度(n = 41)或重度(n = 14)延长的患者中,分别有48.8%和42.9%进行了随访心电图检查。在风险评分≥4的患者中,开始使用氟哌啶醇前进行心电图检查的比例显著更高(p = 0.020)。

结论

尽管许多患者有QTc间期延长的危险因素(包括使用其他QTc间期延长药物)或基线心电图显示QTc间期延长,但随访安全措施有限。应持续努力开发决策支持系统来管理这一风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验